Biochemical Engineering Special Interest Group
biological engineering professionals
04 March 2016

UK Autolus reels in £40 million for CAR-T development

U.K.-based Autolus on Wednesday secured £40 million in funding for development of its CAR-T therapies from Woodford Investment Management and Perceptive Bioscience Investments. The Series B financing builds on £30 million in seed/Series A money, giving Autolus legs to build outs its T-cell pipeline. Formed a little over a year ago, the company was founded on work conducted by Dr. Martin Pule at University College London. Source: BiopharmaDive 4/3/2016

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).